Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Market Reports
Delivering higher value diagnostics
Dr Kevin Robinson had a discussion with Ann Costello, Global Franchise Lead, Centralised Solutions at Roche Diagnostics, following EuroMedLab, regarding how enhancing lab technology, including automated maintenance, is helping to reduce manual operations and the risk of errors
The future of pharmacovigilance and the impact of automation
Pharmacovigilance (PV), the process of identifying, tracking, evaluating and preventing negative outcomes from drug therapies, is a sector that has seen huge growth in recent years. David J. Balderson, Vice President, Global Safety Operations, Sciformix, a Covance company, reports
Butterfly valves: Containment and monitoring for API transfer
Michael Avraam of Chargepoint Technology writes about systems that are critical to preventing HPAPIs harming staff and the bottom line
Establishing a secure supply chain for phyto-APIs
APIs produced from naturally derived materials can be challenging to supply reliably and with consistently high quality. C<sup>2</sup> PHARMA has implemented multiple solutions to ensure supply chain security
Serving up finance
OEMs can help their customers in the pharmaceutical sector to embrace digitalisation with integrated finance, reports Gary Thompson, Sales Director, Siemens Financial Services (UK)
Building a new business model with method lifecycle management
An increased focus on lifecycle management for analytical methods has been seen in recent years from the industry’s regulatory bodies. Method lifecycle management (MLCM) provides an opportunity to continuously improve and ensure quality of data through the application of quality risk management
A natural remedy for brain metastasis
Milk thistle extract might be a promising complementary treatment for cancer patients, reports Andrea Zangara, Scientific Marketing Manager, Euromed
The Manufacturing Chemist outsourcing roundtable: part II
Having talked about upcoming trends, potential growth and in-demand services in Part I, I open the second session by asking the panellists whether they’ll be investing in any particular aspects of their businesses during the next 12 months
A matter of material choice
Dr Kevin Robinson recently caught up with DuPont’s Eric Schmohl, Global Marketing Manager for Tyvek Pharmaceutical Packaging, and Jean-François Teneul, Global Life Sciences Market Leader of Tyvek Protective Apparel, to discuss the importance of protecting both people and product during aseptic fill-&-finish processes
Meeting the global demand for high quality pharmaceutical packaging
Amidst a flurry of recent announcements at the recent DCAT Week in New York, Dr Kevin Robinson sat down with Dr Frank Heinricht, Chairman of the Management Board of SCHOTT AG, to discover how the company is addressing issues in the pharmaceutical value chain, from glass tubing to packaging and the application of artificial intelligence
Continuous manufacturing: making it real
Industry pioneers GEA, Siemens and Perceptive Engineering recently hosted the inaugural Reality of Continuous Pharmaceutical Manufacturing conference in Durham, UK, to examine the current status of going conti and present real-life applications to an international audience. Dr Kevin Robinson reports
Global serialisation: Russian track and trace readiness
Christoph Krähenbühl, Senior Director of Excellis Europe, explains the challenge that the new Russian traceability regulations present to the pharma industry and how all participants in the supply chain must properly prepare to ensure that they become compliant within this new environment
Backend, baffling and buzzing: blockchain
Marco Mohwinckel, healthcare executive and adviser, takes a closer look at the invisible backend technology that has been touted as a revolution
Digitalisation in specialty chemicals and pharmaceuticals
Paige Marie Morse, Industry Director, AspenTech talks to Dr Kevin Robinson about accelerating innovation and optimising the value chain with digital technologies
Supporting precision with precision
As biologics steadily grow in pipeline development and commercialisation, they inherently require precise and meticulous support to ensure effective delivery to the patient
The economic advantages of continuous flow chemistry
Batch production has been the traditional workhorse of the pharmaceutical manufacturing sector. However, economic advantages are taking continuous flow out of the realm of a niche technology for high energy, hazardous reactions to become an essential part of the small molecule manufacturing toolkit
The modularisation of chemical API synthesis
The modularisation of chemical synthesis pathways in pharmaceutical production can improve overall plant efficiency and reduce planning time. Glatt Ingenieurtechnik has optimised the active pharmaceutical ingredient (API) synthesis process and developed bespoke plant designs for several international customers
Rare diseases: understanding the patient journey
In the shadow of Rare Disease Day on 28 February 2019, Dr Kevin Robinson met with Zizi Imatorbhebhe, Senior Director of Strategic Development and Head of PAREXEL’s Rare Disease Center of Excellence (RDCE), to discuss the future of rare disease research
A new paradigm in vaccines and cancer treatments
Specialist pharmaceutical company N4 Pharma is developing Nuvec, a unique non-viral adjuvant delivery system for vaccines and cancer treatments. This silica nanoparticle has the potential to help commercialise cancer immunotherapy drugs and improve the effectiveness of viral vaccines. Dr Kevin Robinson recently caught up with Nigel Theobald, CEO of N4 Pharma, to find out more
Fuelling pharma’s innovation engines
Wishing to assess the current state of Alcami’s target market, Dr Kevin Robinson recently sat down with President and CEO, Dr Stephan Kutzer, to discuss its health, innovation and future aspirations
Broad stripes, bright stars and a thriving pharmaceutical industry: part I
According to one of Stephen Sondheim’s most well-known lyrics, “I like to be in America! OK by me in America!” But, given the geography, politics, population, regulation and funding that are unique to the United States, Dr Kevin Robinson looked west to the Land of the Free to find out how the pharmaceutical industry is faring amongst all the milk and honey
The hidden risk of contamination
Pharmaceutical companies may be unwittingly putting production processes at risk of contamination by fitting pumps with mechanical seals that fail to comply with industry regulations, says John Smiddy, European Sales and Technical Support Director for AESSEAL
A revolutionary method of liquid flow measurement
Pharmaceutical supplier opts for innovative hygienic flowmeter
Next-generation safety testing
In vitro genetic testing offers an ethical alternative to animal testing, which is also cheaper, faster and more reliable
Previous
1
2
3
4
5
6
7
(current)
8
9
Next
Trending Articles
How to avoid sticking and picking in the tableting industry
John Norman and Kevin Queensen of Natoli Engineering explain
Peak identification by LC/MS: Automation versus analyst
High pressure liquid chromatography/mass spectrometry (LC/MS) is an important technique that facilitates the correct and accurate identification of impurities in pharmaceutical products and intermediates
Recombinant versus synthetic peptide synthesis: the perks and drawbacks
Since the introduction of novel peptide drugs into the market, the demand for polypeptide manufacturing has significantly increased, reports Dr Philipp Markolin
The modularisation of chemical API synthesis
The modularisation of chemical synthesis pathways in pharmaceutical production can improve overall plant efficiency and reduce planning time. Glatt Ingenieurtechnik has optimised the active pharmaceutical ingredient (API) synthesis process and developed bespoke plant designs for several international customers
How iPSCs can bridge the translational gap in neuroscience
Affecting more than one in three people, neurological disorders have a vast impact on global health while exacting a tremendous cost, reports Dr Max Mirza, Vice President of Neuroscience Drug Discovery at Sygnature Discovery
Upcoming event
EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications
16 January 2025 | Virtual
See all